E-nnova Health 2022 Award

Enzyme awarded at the E-nnova Health 2022 awards thanks to Komombo.

20 DE SEPTIEMBRE DE 2022.

Enzyme has received the E-nnova Health 2022 award for the initiative «Development of
Artificial Intelligence algorithms to support the diagnosis of Idiopathic Pulmonary Fibrosis
(IPF)» in the «Big Data and Artificial Intelligence» category.

The initiative represents a joint effort between Enzyme and the Hospital Clínic of Barcelona.
It is developed within the framework of Komombo. Both organizations share the vision of
promoting research, development and adoption of tools based on Artificial Intelligence,
Blockchain and Data Science, thus facilitating the detection and diagnosis of diseases.

The E-nnova Health awards recognize the work carried out in 2022 by professionals,
institutions and companies whose digital initiatives provide differential value, contributing to
the sustainability of the system and improving the life of the patient.

TE PUEDE INTERESAR

Komombo: a solution to accelerate the early diagnosis of colon cancer in & collaboration with Roche Diagnostics hospital Clinic of Barcelona.

Komombo is committed to AI to speed up the diagnosis of lung diseases among Hospital Clinic of Barcelona and Enzyme Advising Group.

Contact us